QR Code

Does the Diffusion Profile Differ Between Botulinum Toxin Type a Formulations? Implications for the Management of Post-Stroke Spasticity

Botulinum toxin type A is a first-line treatment for post-stroke spasticity, with selective action at nerve endings and minimal effects beyond the injection site. However, concerns about potential adverse reactions due to toxin diffusion and spread can significantly influence physicians’ therapeutic...

Full description

Saved in:
Main Authors: Alessandro Picelli, Stefano Tamburin, Rita Di Censo, Nicola Smania, Mirko Filippetti
Format: Artigo
Language:Inglês
Published: MDPI AG 2024-11-01
Series:Toxins
Subjects:
botulinum toxins
muscle spasticity
therapeutics
Online Access:https://www.mdpi.com/2072-6651/16/11/480
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items